GEGANT
LIVE

Serial Number

79265476

Owner

ITM Medical Isotopes GmbH

Attorney

Kari Moyer-Henry

Filing Date

Jun 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

GEGANT Trademark

Serial Number: 79265476 • Registration: 6039395

GEGANT is a trademark filed by ITM Medical Isotopes GmbH on June 5, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ITM Medical Isotopes GmbH

Lichtenbergstr. 1

Entity Type: 99

ITG Isotope Technologies Garching GmbH

Lichtenbergstr. 1

Entity Type: 99

Trademark Details

Filing Date

June 5, 2019

Registration Date

April 28, 2020

Published for Opposition

February 11, 2020

Goods & Services

Pharmaceutical advice in relation to radiopharmaceutical products, namely, 68-Ga products for use in medicine for third parties, namely, advice in relation to radiopharmaceuticals for the therapy and diagnosis of diseases, in particular tumour diseases, namely, pharmaceutical advice in relation to radiopharmaceuticals coupled to somatostatin analogues and advice in relation to the manufacture of personalised radiopharmaceutical products containing 68-Ga for use in medicine

Scientific and technological services and research on radiopharmaceutical products, namely, 68-Ga products for use in medicine for third parties, namely, services relating to radiopharmaceuticals for the therapy and diagnosis of diseases and services relating to radiopharmaceuticals coupled to somatostatin analogues for the diagnosis and treatment of tumours, namely, scientific and product research and development

Radiopharmaceutical preparations for use in oncology, namely, radiopharmaceuticals containing Gallium-68 for treating and diagnosing tumours; anti-cancer preparations, namely, Gallium-68 compounds, including 68-Ga chlorides; anti-cancer preparations, namely, Gallium-68 for use in the field of targeted radionuclide therapy of cancers, in particular prostate cancer and neuroendocrine tumours; cancer diagnostic preparations for medical purposes, namely, Gallium-68 compounds, including 68-Ga peptide chelates, in particular 68-Ga-Dotatoc and 68-Ga-Dotatate, 68-Ga salts, in particular 68-Ga chlorides; Gallium-68 for use as radiotracers in pet scans or combined PET/CT scans

Medical apparatus and instruments for use in positron emission tomography (PET) imaging, namely, Ge-68/Ga-68 radionuclide generators for pharmaceutical purposes as source of radionuclides being positron emitters in the field of Positron Emission Tomography - Computed Tomography (PET/CT)

Filing History

TEAS SECTION 71 & 15 RECEIVED
Apr 24, 2026 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 28, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 26, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 8, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 4, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 28, 2020 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 3, 2020 ADCH
REGISTERED-PRINCIPAL REGISTER
Apr 28, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Feb 14, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 29, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 29, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 2, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 30, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 30, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 30, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 30, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2019 TEME
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 20, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 20, 2019 REAP
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 20, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 20, 2019 TROA
REFUSAL PROCESSED BY IB
Oct 5, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 17, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 17, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 4, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 3, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 3, 2019 MAFR
ASSIGNED TO EXAMINER
Aug 30, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 15, 2019 REPR